Purpose

This is a multicenter, single-arm, prospective, observational study designed to evaluate bronchoscopist radiation exposure during standard-of-care image-guided robotic-assisted bronchoscopy (RAB) for sampling of a single pulmonary parenchymal lesion.

Condition

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Operator performing image-guided RAB on adult patients (age ≥18 years old) - A single participating operator per study site - Image-guided RAB procedure is planned for standard of care diagnostic sampling of a single parenchymal lung lesion at participating sites

Exclusion Criteria

  • Operator refusal to participate - Image-guided RAB procedure performed on: - Patients age <18 years old - Pregnant women - Patients undergoing standard of care robotic assisted bronchoscopy with plan to sample >1 pulmonary parenchymal lesion - Patients undergoing standard of care robotic assisted bronchoscopy for lesion localization (injection of dye/marker or fiducial marker deployment) - Patients undergoing standard of care robotic assisted bronchoscopy for a therapeutic intervention

Study Design

Phase
Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Arm Groups

ArmDescriptionAssigned Intervention
Operator Radiation During Image-Guided Robotic-Assisted Bronchoscopy

Recruiting Locations

Memorial Sloan Kettering Cancer Center (All Protocol Activites)
New York 5128581, New York 5128638 10065
Contact:
Or Kalchiem-Dekel, MD
212-639-5061

More Details

Status
Recruiting
Sponsor
Memorial Sloan Kettering Cancer Center

Study Contact

Or Kalchiem-Dekel, MD
212-639-5061
kalchieo@mskcc.org

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.